Photoexcited Porphyrins as a Strong Suppressor of β-Amyloid Aggregation and Synaptic Toxicity
The abnormal assembly of β‐amyloid (Aβ) peptides into neurotoxic, β‐sheet‐rich amyloid aggregates is a major pathological hallmark of Alzheimer’s disease (AD). Light‐induced photosensitizing molecules can regulate Aβ amyloidogenesis. Multiple photochemical analyses using circular dichroism, atomic f...
Saved in:
Published in | Angewandte Chemie (International ed.) Vol. 54; no. 39; pp. 11472 - 11476 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
21.09.2015
WILEY‐VCH Verlag Wiley Subscription Services, Inc |
Edition | International ed. in English |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The abnormal assembly of β‐amyloid (Aβ) peptides into neurotoxic, β‐sheet‐rich amyloid aggregates is a major pathological hallmark of Alzheimer’s disease (AD). Light‐induced photosensitizing molecules can regulate Aβ amyloidogenesis. Multiple photochemical analyses using circular dichroism, atomic force microscopy, dot blot, and native gel electrophoresis verified that photoactivated meso‐tetra(4‐sulfonatophenyl)porphyrin (TPPS with M=2H+, Zn2+, Cu2+, Mn2+) successfully inhibits Aβ aggregation in vitro. Furthermore, Aβ toxicity was relieved in the photoexcited‐TPPS‐treated Drosophila AD model. TPPS suppresses neural cell death, synaptic toxicity, and behavioral defects in the Drosophila AD model under blue light illumination. Behavioral phenotypes, including larval locomotion defect and short lifespan caused by Aβ overexpression, were also rescued by blue light‐excited TPPS.
Photoinduced inhibition of β‐amyloid (Aβ) aggregation was achieved with meso‐tetra(4‐sulfonatophenyl) porphyrin (TPPS, with M=2H+, Zn2+, Cu2+, Mn2+) under blue LED illumination. The light‐driven efficacy of TPPS is attributed to the strong binding affinity of TPPS to Aβ and photooxidation of Aβ. Aβ toxicity was relieved in a photoexcited‐TPPS‐treated Drosophila Alzheimer’s disease model. |
---|---|
Bibliography: | Intelligent Synthetic Biology Center of Global Frontier R&D Project - No. 2011-0031957 National Research Foundation - No. NRF-2013R1A2A1A05005468; No. 2014M3A9D8034462 ark:/67375/WNG-B50XQBK2-5 This work was supported by the Brain Pool program from KOFST (to S.L.), the KRIBB research initiative program, and the grants from the National Research Foundation (NRF) via the National Leading Research Laboratory (NRF-2013R1A2A1A05005468), 2014M3A9D8034462, and the Intelligent Synthetic Biology Center of Global Frontier R&D Project (2011-0031957) and from Cooperative Program for Agriculture Science and Technology Development (PJ01086401), Republic of Korea. Cooperative Program for Agriculture Science and Technology Development - No. PJ01086401 istex:548D95BAF6C21178F74213D3922110F179F58F78 ArticleID:ANIE201504310 This work was supported by the Brain Pool program from KOFST (to S.L.), the KRIBB research initiative program, and the grants from the National Research Foundation (NRF) via the National Leading Research Laboratory (NRF‐2013R1A2A1A05005468), 2014M3A9D8034462, and the Intelligent Synthetic Biology Center of Global Frontier R&D Project (2011‐0031957) and from Cooperative Program for Agriculture Science and Technology Development (PJ01086401), Republic of Korea. These authors contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.201504310 |